Pembrolizumab (PD-1 Blocking Antibody): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Esophageal Squamous Cell Carcinoma	1
Head and Neck Cancer	1
Lung cancer	1
Malignant Melanoma	1
Melanoma	1
Small Cell and Non-small Cell Lung Cancer	1
Solid Tumor	1
Squamous Cell Carcinoma of Larynx	1
Squamous Cell Carcinoma of Nasopharynx	1
Squamous Cell Carcinoma of Oral Cavity	1
Squamous Cell Carcinoma of Other Specified Sites of Skin	1

RAPA-201 Therapy of Solid Tumors
NCT05144698 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

1 recruiting trial across 11 conditions.

No. For the full record, search ClinicalTrials.gov.